Krystal Biotech KRYS
NASDAQ KRYS
$326.45 +1.14 (+0.35%)
As of: Oct 2, 2026 · 12:19 PM EDT

Krystal Biotech (KRYS) Depreciation & Amortization (CF) (2016 - 2026)

Updated

Krystal Biotech's Depreciation & Amortization (CF) was $1.4 million in Q2 2026, up 7.7% from $1.3 million a year earlier but down 8.0% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Krystal Biotech's Depreciation & Amortization (CF) was $5.85 million through Jun 30, 2026, up 8.1% year-over-year; for FY2025, it came in at $5.72 million, down 4.6% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 25.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $6 million in FY2024 (+19.8%), $5.01 million in FY2023 (+23.5%), $4.06 million in FY2022 (+46.4%) and $2.77 million in FY2021 (+49.6%).
  • Quarterly Depreciation & Amortization (CF) has moved between $705,000 (Q1 2023) and $1.8 million (Q2 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for four straight quarters, with growth averaging 6.7% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2024 (growth of 102.4%); the worst was Q1 2023 (a decline of 30.5%).
  • Per Business Quant data, KRYS's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.52 million (Q1 2026), $1.52 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn 1.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Mar 31, 2026 1.52 Mn
Dec 31, 2025 1.52 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 1.41 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 1.30 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 826,000.00
Jun 30, 2023 1.04 Mn
Mar 31, 2023 705,000.00
Dec 31, 2022 1.09 Mn
Sep 30, 2022 975,000.00
Jun 30, 2022 976,000.00
Mar 31, 2022 1.02 Mn
Dec 31, 2021 784,000.00
Sep 30, 2021 783,000.00
API Access

Krystal Biotech Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KRYS&period=max&api_key=YOUR_API_KEY